AzTrials
AzTrials

Sleep Disordered BreathingSDB-ZRWNCT02632162

Prevalence, Severity and Natural Course of Sleep Apnea After Cardiac Surgery

An observational study of Sleep Disordered Breathing, run by Zürcher RehaZentrum Wald at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

Sleep disordered breathing (SDB) is common in cardiovascular patients. Patients after cardiac surgery will be screened for SDB with the ApnoeLink device at the beginning of cardiac Rehabilitation and then after 3 weeks and 3 months. Read more about this study

Who is it for?
Any age
Conditions the study is for
Sleep Disordered Breathing
What is being tested?
screening
How many people
450 participants
Where
1 siteSwitzerland
Study dates
May 2016to Dec 2020
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: cardiac surgery < 2 weeks

Who may be able to join

  • cardiac surgery or orthopedic surgery <2 weeks

Who cannot join

  • known SDB

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Zürcher RehaZentrum Wald

    Wald, 8636

Other trials in Switzerland

About this study

Sleep disordered breathing (SDB) is common in cardiovascular patients. Patients after cardiac surgery will be screened for SDB with the ApnoeLink device at the beginning of cardiac Rehabilitation and then after 3 weeks and 3 months.

Read the detailed description

Objective(s) of the project

  • Evaluate the prevalence of sleep apnea after cardiac surgery
  • Compare results interindividually (group A vs. group B) and intraindividually (longitudinal assessment after 3 months)

Outcome(s)

  • Prevalence of sleep apnoe at day 1 and 20 of rehabilitation and 3 months after cardiac surgery
  • composite endpoint of events at 3 months (cardiovascular death, non-fatal myocardial infarction, non-fatal cardiac arrest, revascularisation procedure, new atrial fibrillation and stroke)
  • change in 6-minute walking test (6-MWT)
  • impact of heart surgery on sleep apnoe
Being tested
screening
Medical subject headings
Sleep Apnea Syndromes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • screeningOther

    Screening for sleep disordered breathing with the ApnoeLink Air device

Study groups in NCT02632162
Study groupRoleWhat they receive
cardiac surgeryactive Group screening
Receives: Other: screening
orthopedic surgerycontrol Group screening
Receives: Other: screening

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of SDB prevalence after cardiac surgery measured with ApnoeLink Air device

    • Prevalence of sleep apnoe at day 1 and 20 of rehabilitation and 3 months after cardiac surgery assessed with the ApnoeLink Air device (ResMed)

    Measured: day 1, day 20, 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Dec 2015 (estimated)
  2. Study startMay 2016
  3. Primary completionAug 2018
  4. Study completionDec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
450 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02632162
Sponsor's protocol ID
ZRW-SDB-2015
Acronym
SDB-ZRW
Status last verified
Sep 2026
First submitted
2 Dec 2015
Last updated
2 Sep 2026
Results posted
No
Data monitoring committee
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in